MARKET

ARAY

ARAY

Accuray
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.20
-0.08
-1.47%
Opening 11:44 02/25 EST
OPEN
5.29
PREV CLOSE
5.28
HIGH
5.38
LOW
5.19
VOLUME
325.68K
TURNOVER
--
52 WEEK HIGH
6.02
52 WEEK LOW
1.330
MARKET CAP
483.29M
P/E (TTM)
62.91
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The oncology information systems market is projected to reach USD 9.5 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 7.4%
New York, Feb 24, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...
GlobeNewswire · 1d ago
Global Oncology Information System Market Size 2021, by Product, Professional Service, Application, End User: Covid 19 Impact Outlook, and Forecast 2020-2026
Feb 24, 2021 (The Expresswire) -- Oncology Information System Market is valued at 3.20 USD Billion in 2019 and expected to reach USD 5.32 Billion by 2026...
The Express Wire · 1d ago
Healthcare Automation Market Research Development, Top Companies, Trends And Growth 2018 To 2028
Feb 24, 2021 (Heraldkeepers) -- The Healthcare Automation Market is expected to exceed more than US$ 60 Billion by 2024 at a CAGR of 9% in the given forecast...
Heraldkeepers · 1d ago
Accuray to Participate in the Cowen 41st Annual Health Care Conference
Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the Cowen Annual Health Care Conference. The management team is scheduled to participate in a virtual Fireside Chat on Tuesday, March 2nd at 11:50 am PACIFIC / 2:50 pm EASTERN. A live...
PR Newswire · 1d ago
Robotic Surgical Procedures Market worth USD 19.03 Billion at 21.8% CAGR; Presence of Prominent Pharmaceutical Enterprises to Boost Demand in North America
According to the report, Robotic Surgical Procedures market size is projected to reach USD 19.03 Billion by 2027. Robotic Surgical Procedures Market was worth 5.32 billion in 2019 and will exhibit a CAGR of 21.8% during the forecast period. The global robo...
GlobeNewswire · 2d ago
Global Linear Particle Accelerators Market Growth 2021 Latest Trends, Overview, Growth Factor, Demand and Forecast Research Report to 2026
The Express Wire · 2d ago
Radiotherapy Market Research Report 2020-2024 By Players, Regions, Product Types And Applications
Feb 23, 2021 (AmericaNewsHour) -- Global Radiotherapy Market AnalysisAccording to Verified Market Research, The Global Radiotherapy Market was valued at USD...
AmericaNewsHour · 2d ago
Commercial Robotics Market Size Research Report 2021 by Growth Rate, Revenue Estimates, Market Dynamics, Industry Trends and Forecast to 2027 Says Absolute Reports
Feb 22, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Commercial Robotics Market” research...
The Express Wire · 3d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ARAY. Analyze the recent business situations of Accuray through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ARAY stock price target is 8.20 with a high estimate of 10.00 and a low estimate of 7.00.
EPS
Institutional Holdings
Institutions: 193
Institutional Holdings: 70.39M
% Owned: 75.77%
Shares Outstanding: 92.90M
TypeInstitutionsShares
Increased
45
4.41M
New
35
2.90M
Decreased
41
5.87M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.65%
Healthcare Equipment & Supplies
-0.65%
Key Executives
Chairman/Director
Louis Lavigne
President/Chief Executive Officer/Director
Joshua Levine
Chief Financial Officer/Senior Vice President
Shig Hamamatsu
Chief Financial Officer/Senior Vice President
Shigeyuki Hamamatsu
Senior Vice President/Chief Administrative Officer
Patrick Spine
Senior Vice President/General Counsel/Secretary
Jesse Chew
Senior Vice President
Jim Dennison
Senior Vice President
Suzanne Winter
Director
Byron Scott
Independent Director
Elizabeth Davila
Independent Director
James Hindman
Independent Director
Beverly Huss
Independent Director
Anne Le Grand
Independent Director
Richard Pettingill
Independent Director
Joseph Whitters
  • Dividends
  • Splits
  • Insider Activity
No Data
About ARAY
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Webull offers kinds of Accuray Incorporated stock information, including NASDAQ:ARAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ARAY stock methods without spending real money on the virtual paper trading platform.